Terminated NA INTERVENTIONAL 3-arm NCT03531502

Initial Management of Patients Receiving a Single Shock (IMPRESS) (IMPRESS)

Sponsor: Medtronic

Interventions Non-Invasive Programmed Stimulation (NIPS) Standard Medical Therapy Ventricular Tachycardia Ablation

Updated 8 times since 2018 Last updated: Apr 11, 2023 Started: Apr 9, 2018 Primary completion: Apr 4, 2023 Completion: Apr 4, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

lack of funding

Other terminated trials from Medtronic

See all terminations from Medtronic

A NA clinical study on Ventricular Tachycardia, this trial is terminated or withdrawn. The trial is conducted by Medtronic and has accumulated 8 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
May 2023 — Jul 2024 [monthly]

Terminated NA

Status: Recruiting → Terminated
Nov 2021 — May 2023 [monthly]

Recruiting NA
Apr 2021 — Nov 2021 [monthly]

Recruiting NA

▶ Show 3 earlier versions

Jan 2021 — Apr 2021 [monthly]

Recruiting NA
Oct 2019 — Jan 2021 [monthly]

Recruiting NA
Jun 2018 — Oct 2019 [monthly]

Recruiting NA

First recorded

Apr 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic
Saint Luke's Health System

Data source: Saint Luke's Health System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kansas City, United States